IRIS Accounts Production v25.4.12.37 16185145 Board of Directors 15.1.25 31.1.26 31.1.26 No description of principal activity false true false false true true Ordinary 1.00000 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 16185145 2025-01-14 16185145 2026-01-31 16185145 2025-01-15 2026-01-31 16185145 2025-01-14 16185145 ns15:EnglandWales 2025-01-15 2026-01-31 16185145 ns14:PoundSterling 2025-01-15 2026-01-31 16185145 ns10:Director1 2025-01-15 2026-01-31 16185145 ns10:PrivateLimitedCompanyLtd 2025-01-15 2026-01-31 16185145 ns10:SmallEntities 2025-01-15 2026-01-31 16185145 ns10:AuditExempt-NoAccountantsReport 2025-01-15 2026-01-31 16185145 ns10:SmallCompaniesRegimeForDirectorsReport 2025-01-15 2026-01-31 16185145 ns10:SmallCompaniesRegimeForAccounts 2025-01-15 2026-01-31 16185145 ns10:FullAccounts 2025-01-15 2026-01-31 16185145 ns10:EntityHasNeverTraded 2025-01-15 2026-01-31 16185145 ns10:OrdinaryShareClass1 2025-01-15 2026-01-31 16185145 1 ns10:OrdinaryShareClass1 2025-01-15 2026-01-31 16185145 ns10:Director2 2025-01-15 2026-01-31 16185145 ns10:RegisteredOffice 2025-01-15 2026-01-31 16185145 ns5:ShareCapital 2026-01-31 16185145 ns10:OrdinaryShareClass1 2026-01-31

REGISTERED NUMBER: 16185145 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 15 JANUARY 2025 TO 31 JANUARY 2026

FOR

ELEVATE BIO HEALTH LTD

| ELEVATE BIO HEALTH LTD (REGISTERED NUMBER: 16185145) |

CONTENTS OF THE FINANCIAL STATEMENTS

for the Period 15 January 2025 to 31 January 2026

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| ELEVATE BIO HEALTH LTD |

COMPANY INFORMATION

for the Period 15 January 2025 to 31 January 2026

| DIRECTORS: | Mr C N Falconer

| Mr C O A Ojeh

| REGISTERED OFFICE: | Unit 4 Grovelands

| Boundary Way

| Hemel Hempstead

| Hertfordshire

| HP2 7TE

| REGISTERED NUMBER: | 16185145 (England and Wales)

| ELEVATE BIO HEALTH LTD (REGISTERED NUMBER: 16185145) |

BALANCE SHEET

31 January 2026

| Notes | £ |

| CURRENT ASSETS

| Cash in hand | 50 |  |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 50 |  |

| CAPITAL AND RESERVES

| Called up share capital | 4 | 50 |  |

| SHAREHOLDERS' FUNDS | 50 |  |

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the period ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 April 2026 and were signed on its behalf by:

Mr C N Falconer - Director

| ELEVATE BIO HEALTH LTD (REGISTERED NUMBER: 16185145) |

NOTES TO THE FINANCIAL STATEMENTS

for the Period 15 January 2025 to 31 January 2026

1. | STATUTORY INFORMATION

| Elevate Bio Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 2 .

4. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal

| value: | £ |

| 100 | Ordinary | £1 | 50 |  |

| 100 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.